TWD 90.3
(-1.85%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 177.9 Million TWD | 25.53% |
2022 | 141.71 Million TWD | 39.32% |
2021 | 101.72 Million TWD | -20.53% |
2020 | 128 Million TWD | 6.05% |
2019 | 120.7 Million TWD | 38.95% |
2018 | 86.86 Million TWD | 406.85% |
2017 | 17.13 Million TWD | 165.26% |
2016 | -26.26 Million TWD | -147.89% |
2015 | 54.84 Million TWD | 347.64% |
2014 | -22.14 Million TWD | -154.88% |
2013 | 40.35 Million TWD | -35.36% |
2012 | 62.43 Million TWD | 22.03% |
2011 | 51.16 Million TWD | 845.35% |
2010 | -6.86 Million TWD | 86.93% |
2009 | -52.53 Million TWD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 51.7 Million TWD | 31.47% |
2024 Q2 | 67.81 Million TWD | 31.15% |
2023 Q1 | 32.77 Million TWD | 10.94% |
2023 FY | 177.9 Million TWD | 25.53% |
2023 Q4 | 39.32 Million TWD | -27.97% |
2023 Q3 | 54.6 Million TWD | 6.66% |
2023 Q2 | 51.19 Million TWD | 56.18% |
2022 FY | 141.71 Million TWD | 39.32% |
2022 Q4 | 29.54 Million TWD | -35.12% |
2022 Q3 | 45.54 Million TWD | 14.85% |
2022 Q2 | 39.65 Million TWD | 47.04% |
2022 Q1 | 26.97 Million TWD | 6.32% |
2021 FY | 101.72 Million TWD | -20.53% |
2021 Q1 | 24.64 Million TWD | -30.19% |
2021 Q2 | 31.62 Million TWD | 28.36% |
2021 Q3 | 20.08 Million TWD | -36.5% |
2021 Q4 | 25.36 Million TWD | 26.29% |
2020 FY | 128 Million TWD | 6.05% |
2020 Q1 | 36.32 Million TWD | -8.89% |
2020 Q2 | 22.38 Million TWD | -38.37% |
2020 Q3 | 34 Million TWD | 51.91% |
2020 Q4 | 35.29 Million TWD | 3.8% |
2019 Q2 | 25.38 Million TWD | -14.73% |
2019 FY | 120.7 Million TWD | 38.95% |
2019 Q4 | 39.86 Million TWD | 55.2% |
2019 Q3 | 25.68 Million TWD | 1.18% |
2019 Q1 | 29.77 Million TWD | -5.57% |
2018 Q2 | 3.63 Million TWD | -89.78% |
2018 FY | 86.86 Million TWD | 406.85% |
2018 Q3 | 16.14 Million TWD | 344.45% |
2018 Q4 | 31.52 Million TWD | 95.24% |
2018 Q1 | 35.56 Million TWD | 102.8% |
2017 Q3 | 801 Thousand TWD | -11.69% |
2017 FY | 17.13 Million TWD | 165.26% |
2017 Q2 | 907 Thousand TWD | 143.09% |
2017 Q1 | -2.1 Million TWD | -109.78% |
2017 Q4 | 17.53 Million TWD | 2089.26% |
2016 Q2 | 662 Thousand TWD | 225.38% |
2016 Q3 | -47.93 Million TWD | -7340.33% |
2016 Q4 | 21.53 Million TWD | 144.93% |
2016 FY | -26.26 Million TWD | -147.89% |
2016 Q1 | -528 Thousand TWD | -104.95% |
2015 Q2 | 5.26 Million TWD | -61.76% |
2015 Q4 | 10.67 Million TWD | -57.56% |
2015 FY | 54.84 Million TWD | 347.64% |
2015 Q1 | 13.75 Million TWD | 161.21% |
2015 Q3 | 25.14 Million TWD | 378.01% |
2014 Q2 | 584 Thousand TWD | -47.48% |
2014 FY | -22.14 Million TWD | -154.88% |
2014 Q4 | -22.47 Million TWD | -1549.16% |
2014 Q3 | -1.36 Million TWD | -333.39% |
2014 Q1 | 1.11 Million TWD | -80.55% |
2013 Q2 | 8.99 Million TWD | 24.8% |
2013 Q4 | 5.71 Million TWD | -68.99% |
2013 FY | 40.35 Million TWD | -35.36% |
2013 Q1 | 7.2 Million TWD | -74.31% |
2013 Q3 | 18.43 Million TWD | 104.96% |
2012 Q4 | 28.05 Million TWD | 36.19% |
2012 Q3 | 20.6 Million TWD | 153.76% |
2012 Q1 | 5.68 Million TWD | -60.14% |
2012 Q2 | 8.11 Million TWD | 42.77% |
2012 FY | 62.43 Million TWD | 22.03% |
2011 Q3 | 15.42 Million TWD | 0.0% |
2011 FY | 51.16 Million TWD | 845.35% |
2011 Q4 | 14.26 Million TWD | -7.54% |
2011 Q2 | - TWD | 0.0% |
2010 FY | -6.86 Million TWD | 86.93% |
2010 Q4 | - TWD | 0.0% |
2009 FY | -52.53 Million TWD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Nang Kuang Pharmaceutical Co., Ltd. | 198.4 Million TWD | 10.337% |
Maxigen Biotech Inc. | 165.82 Million TWD | -7.28% |
Bionime Corporation | 6.2 Million TWD | -2765.196% |
Pegavision Corporation | 1.65 Billion TWD | 89.257% |
Visco Vision Inc. | 301.61 Million TWD | 41.017% |